Viewing nowPalmrica Capsule 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
(Co., Ltd.) Korea Pharmbio

MFDS item code 201603115 · Approved 2016.05.31 · Insurance code 659901170
Treatment of peripheral and central neuropathic pain, adjunctive treatment of partial seizures in epilepsy, improvement of fibromyalgia.
This medication is used in adults to treat peripheral and central neuropathic pain. It is also administered as an adjunctive treatment in patients with epilepsy who have partial seizures or accompanying generalized symptoms. Additionally, it is effective for the treatment of fibromyalgia. In summary, it is used for the alleviation of neuropathic pain, control of epileptic seizures, and improvement of symptoms of fibromyalgia.
This medication, as Pregabalin, is orally administered in divided doses twice daily, regardless of food. 1. Neuropathic Pain - Peripheral neuropathic pain: The initial dose is 150 mg once daily. After 3 to 7 days, the dose may be increased to 300 mg per day, and if necessary, it may be increased to a maximum of 600 mg at intervals of 7 days. - Central neuropathic pain: Starting dose is 150 mg
There is insufficient safety and efficacy data for children under 12 years old and adolescents aged 12-17, so administration is not recommended.
This medication may increase the risk of suicidal thoughts and behavior, so if mood changes or symptoms of depression occur during use, consultation with a doctor should be sought immediately. Patients with allergies to any of the ingredients in this medication or those with certain genetic lactose metabolism disorders should not take it. Diabetic patients should exercise caution, as weight gain may necessitate adjustment of blood sugar control medications. If symptoms of angioedema appear, the medication should be discontinued immediately, and elderly patients should be cautious of dizziness or drowsiness that increases the risk of falls. If blurred vision or changes in vision occur, discontinuing the medication may improve the symptoms. Sudden discontinuation of this medication may result in withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so it should be stopped gradually as directed by a doctor. Due to the potential for drug abuse, patients should inform their doctor of their mental health status and history of drug use, taking extra care if there is a risk of abuse. Patients with impaired kidney function may require dose adjustments. Patients with heart disease should exercise caution when taking this medication, particularly those with congestive heart failure. Taking this medication with central nervous system depressants or opioid analgesics may increase the risk of respiratory depression, so caution is advised. Pregnant women should not use this medication during early pregnancy due to the risk of fetal malformations, and women of childbearing age should use effective birth control methods. Lactating women should consider the potential transfer of this medication into breast milk, which may affect the infant, and may need to discontinue breastfeeding or the medication. This medication can cause dizziness and drowsiness, necessitating caution when driving or operating dangerous machinery. Severe skin reactions may occur infrequently, so if any skin abnormalities appear, the medication should be stopped immediately, and consultation with a doctor should be sought. In the case of overdose, symptoms may include confusion, drowsiness, and depression; treatment such as hemodialysis may be needed if necessary. Children and elderly patients may be more sensitive to the effects of this medication, so extra caution should be observed when they are using it, keeping it out of reach of children.
Rash, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain in oral/ocular mucosa, shortness of breath or difficulty in breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis,
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and the temperature should be kept between 15 degrees and 30 degrees Celsius in a cool place. By storing it this way, the efficacy of the medication can be well maintained, and it can be used safely.
A white or light yellow powder contained in a white opaque hard capsule.
30 capsules/bottle, 60 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
(Co., Ltd.) Korea Pharmbio

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.